ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Knockdown of DLGAP5 suppresses cell proliferation, induces G2/M phase arrest and apoptosis in ovarian cancer.

Zhang Huijun; Liu Yuan; Tang Shengchun; Qin Xiaomin; Li Lin; Zhou Jinting; Zhang Jing; Liu Bo
Experimental and therapeutic medicine2021DOI: 10.3892/ETM.2021.10680
3被引4阅读
引用收藏
分享

摘要

Discs large-associated protein 5 (DLGAP5) is a microtubule-associated protein and is reported to exert oncogenic role in tumorigenesis, including lung cancer and hepatocellular carcinoma. However, the prognostic value and biological function of DLGAP5 in ovarian cancer (OC) still remain unclear. The present study investigated the expression pattern of DLGAP5 by searching the Oncomine microarray database. The correlation between DLGAP5 and survival prognosis of OC patients was analyzed by the online tool KM-plotter. Knockdown of DLGAP5 was achieved by transfection with small interfering RNA targeting DLGAP5 in two OC cell lines (SKOV3 and CAOV3). Cell proliferation was assessed by Cell Counting Kit-8 assay and colony-formation assay. Flow cytometry was utilized to determine the effects of DLGAP5 on cell cycle distribution and apoptosis. The present study data showed that DLGAP5 was significantly upregulated in OC and its higher expression was associated with poor survival prognosis. Knockdown of DLGAP5 significantly suppressed cell proliferation, induced cell cycle G2/M phase arrest and apoptosis. Western blot analysis further demonstrated that DLGAP5 knockdown downregulated the expression of CDK1, Cyclin B1 and Bcl-2, but upregulated Bax expression. Collectively, these data demonstrate that DLGAP5 might be a promising prognostic therapeutic target for OC treatment.

学科与关键词

关键词
DLGAP5G2/Mapoptosisovarian cancerproliferation
相关
加载中…
  • MicroRNA-409-5p inhibits cell proliferation, and induces G2/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells
    Li, Weiwei; Lin, Ji; Huang, Jianfen; Chen, Zhuoying; Sheng, Qunying; Yang, Fang; Yang, Xue; Cui, Xiaojie*Oncology Letters, 2022, 24(2): 261.被引 2
  • NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer
    Zhu, Xiaohua; Xie, YingYing; Huang, Wenyan; Chen, Zigui; Guo, SuiQun*BMC CANCER, 2022, 22(1): 339.被引 6
  • Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer
    Chen, Xueping; Zha, Zhiqiang; Wang, Yu; Chen, Yun; Pang, Menglan; Huang, Liping*; Chen, YaoJournal of Ovarian Research, 2022, 15(1): 69.
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental and therapeutic medicine
发表日期
2021
卷期
第 22 卷, 第 5 期
DOI
10.3892/ETM.2021.10680
成果收录
CHINAJOURNAL

作者

  • Z

    Zhang Huijun (第一作者)

  • L

    Liu Yuan

查看全部 8 位作者收起作者
  • T

    Tang Shengchun

  • Q

    Qin Xiaomin

  • L

    Li Lin

  • Z

    Zhou Jinting

  • Z

    Zhang Jing

  • L

    Liu Bo

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417